XML 46 R35.htm IDEA: XBRL DOCUMENT v3.24.2
Discontinued Operations Sale of Infusionz to Bloomios (Tables)
9 Months Ended
Mar. 31, 2024
Discontinued Operations Sale of Infusionz to Bloomios  
Schedule of inventory or working capital

Tangible assets, inventory / working capital*

 

$(1,344,000 )

Tangible assets, warehouse and manufacturing equipment, net of accumulated depreciation*

 

 

(679,327 )

Goodwill

 

 

(2,413,814 )

Intangible assets, net of accumulated amortization

 

 

(946,996 )

Accrued and incurred expenses related to the transaction and additional working capital*

 

 

(2,051,500 )

Consideration received, including cash, debt and equity, net

 

 

15,000,000

 

Total gain recognized

 

$7,564,363

 

Schedule of due from Bloomios

Advance for payroll

 

$50,000

 

Operating expense

 

 

652,891

 

Management fees

 

 

685,600

 

Excess working capital

 

 

388,565

 

Accrued Interest

 

 

247,885

 

Subtotal due from Bloomios

 

$2,024,941

 

Reserve

 

 

1,179,498

 

Total due from Bloomios

 

$845,443